Improving health evaluations to capture wider value of therapeutics and incentivise innovation
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Public Health |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpubh.2023.1119652/full |
_version_ | 1797855050465280000 |
---|---|
author | Mei Sum Chan Jack C. Kowalik Tom Ashfield Jonathan Pearson-Stuttard Jonathan Pearson-Stuttard |
author_facet | Mei Sum Chan Jack C. Kowalik Tom Ashfield Jonathan Pearson-Stuttard Jonathan Pearson-Stuttard |
author_sort | Mei Sum Chan |
collection | DOAJ |
first_indexed | 2024-04-09T20:16:16Z |
format | Article |
id | doaj.art-4677c1e2c2fa429cb2532afe0332c3d6 |
institution | Directory Open Access Journal |
issn | 2296-2565 |
language | English |
last_indexed | 2024-04-09T20:16:16Z |
publishDate | 2023-03-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Public Health |
spelling | doaj.art-4677c1e2c2fa429cb2532afe0332c3d62023-03-31T06:52:26ZengFrontiers Media S.A.Frontiers in Public Health2296-25652023-03-011110.3389/fpubh.2023.11196521119652Improving health evaluations to capture wider value of therapeutics and incentivise innovationMei Sum Chan0Jack C. Kowalik1Tom Ashfield2Jonathan Pearson-Stuttard3Jonathan Pearson-Stuttard4Health Analytics, Lane Clark & Peacock LLP, London, United KingdomUK Health & Value, Pfizer Ltd., Tadworth, United KingdomUK Medical Affairs - Anti-infectives, Pfizer Ltd., Tadworth, United KingdomHealth Analytics, Lane Clark & Peacock LLP, London, United KingdomDepartment of Epidemiology and Biostatistics, Imperial College London, London, United Kingdomhttps://www.frontiersin.org/articles/10.3389/fpubh.2023.1119652/fullelements of valueinsurance valueantimicrobial resistancepandemicsvalue assessment |
spellingShingle | Mei Sum Chan Jack C. Kowalik Tom Ashfield Jonathan Pearson-Stuttard Jonathan Pearson-Stuttard Improving health evaluations to capture wider value of therapeutics and incentivise innovation Frontiers in Public Health elements of value insurance value antimicrobial resistance pandemics value assessment |
title | Improving health evaluations to capture wider value of therapeutics and incentivise innovation |
title_full | Improving health evaluations to capture wider value of therapeutics and incentivise innovation |
title_fullStr | Improving health evaluations to capture wider value of therapeutics and incentivise innovation |
title_full_unstemmed | Improving health evaluations to capture wider value of therapeutics and incentivise innovation |
title_short | Improving health evaluations to capture wider value of therapeutics and incentivise innovation |
title_sort | improving health evaluations to capture wider value of therapeutics and incentivise innovation |
topic | elements of value insurance value antimicrobial resistance pandemics value assessment |
url | https://www.frontiersin.org/articles/10.3389/fpubh.2023.1119652/full |
work_keys_str_mv | AT meisumchan improvinghealthevaluationstocapturewidervalueoftherapeuticsandincentiviseinnovation AT jackckowalik improvinghealthevaluationstocapturewidervalueoftherapeuticsandincentiviseinnovation AT tomashfield improvinghealthevaluationstocapturewidervalueoftherapeuticsandincentiviseinnovation AT jonathanpearsonstuttard improvinghealthevaluationstocapturewidervalueoftherapeuticsandincentiviseinnovation AT jonathanpearsonstuttard improvinghealthevaluationstocapturewidervalueoftherapeuticsandincentiviseinnovation |